Annual Accounts Payable
$2.76 M
-$881.00 K-24.22%
December 31, 2023
Summary
- As of February 12, 2025, FULC annual accounts payable is $2.76 million, with the most recent change of -$881.00 thousand (-24.22%) on December 31, 2023.
- During the last 3 years, FULC annual accounts payable has fallen by -$1.32 million (-32.41%).
- FULC annual accounts payable is now -42.42% below its all-time high of $4.79 million, reached on December 31, 2021.
Performance
FULC Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.04 M
+$457.00 K+12.75%
September 30, 2024
Summary
- As of February 12, 2025, FULC quarterly accounts payable is $4.04 million, with the most recent change of +$457.00 thousand (+12.75%) on September 30, 2024.
- Over the past year, FULC quarterly accounts payable has increased by +$1.28 million (+46.57%).
- FULC quarterly accounts payable is now -32.68% below its all-time high of $6.00 million, reached on March 31, 2022.
Performance
FULC Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
FULC Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.2% | +46.6% |
| 3 y3 years | -32.4% | +46.6% |
| 5 y5 years | +118.3% | +46.6% |
FULC Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.4% | at low | -32.7% | +48.1% |
| 5 y | 5-year | -42.4% | +26.1% | -32.7% | +84.9% |
| alltime | all time | -42.4% | +118.3% | -32.7% | +219.9% |
Fulcrum Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.04 M(+12.8%) |
| Jun 2024 | - | $3.58 M(-7.1%) |
| Mar 2024 | - | $3.86 M(+39.9%) |
| Dec 2023 | $2.76 M(-24.2%) | $2.76 M(-22.9%) |
| Sep 2023 | - | $3.57 M(-8.6%) |
| Jun 2023 | - | $3.91 M(+3.5%) |
| Mar 2023 | - | $3.78 M(+3.8%) |
| Dec 2022 | $3.64 M(-24.0%) | $3.64 M(+33.4%) |
| Sep 2022 | - | $2.73 M(-49.3%) |
| Jun 2022 | - | $5.38 M(-10.3%) |
| Mar 2022 | - | $6.00 M(+25.4%) |
| Dec 2021 | $4.79 M | $4.79 M(+28.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $3.74 M(-16.8%) |
| Jun 2021 | - | $4.50 M(-6.2%) |
| Mar 2021 | - | $4.80 M(+17.6%) |
| Dec 2020 | $4.08 M(+86.6%) | $4.08 M(+12.2%) |
| Sep 2020 | - | $3.63 M(+1.8%) |
| Jun 2020 | - | $3.57 M(-9.3%) |
| Mar 2020 | - | $3.94 M(+80.1%) |
| Dec 2019 | $2.19 M(+73.1%) | $2.19 M(-51.8%) |
| Sep 2019 | - | $4.53 M(+47.1%) |
| Jun 2019 | - | $3.08 M(+22.2%) |
| Mar 2019 | - | $2.52 M(+99.7%) |
| Dec 2018 | $1.26 M(-24.5%) | $1.26 M |
| Dec 2017 | $1.67 M | - |
FAQ
- What is Fulcrum Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics annual accounts payable year-on-year change?
- What is Fulcrum Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics quarterly accounts payable year-on-year change?
What is Fulcrum Therapeutics annual accounts payable?
The current annual accounts payable of FULC is $2.76 M
What is the all time high annual accounts payable for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high annual accounts payable is $4.79 M
What is Fulcrum Therapeutics annual accounts payable year-on-year change?
Over the past year, FULC annual accounts payable has changed by -$881.00 K (-24.22%)
What is Fulcrum Therapeutics quarterly accounts payable?
The current quarterly accounts payable of FULC is $4.04 M
What is the all time high quarterly accounts payable for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high quarterly accounts payable is $6.00 M
What is Fulcrum Therapeutics quarterly accounts payable year-on-year change?
Over the past year, FULC quarterly accounts payable has changed by +$1.28 M (+46.57%)